A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

NCT05137067 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Lung Cancer
Prostate Cancer

Interventions

DIETARY_SUPPLEMENT: Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel) plus Dietary Supplement (RaproCell)
DRUG: Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel) plus placebo
DRUG: Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel).

Sponsor

Optimal Health Research